UnitedHealth Group Incorporated $UNH Stock: Diversified Trust Co Decreases Stake

Diversified Trust Co decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 26.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 37,680 shares of the healthcare conglomerate’s stock after selling 13,751 shares during the quarter. Diversified Trust Co’s holdings in UnitedHealth Group were worth $13,832,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in UNH. General Partner Inc. purchased a new position in UnitedHealth Group during the third quarter valued at $512,000. PBCay One RSC Ltd bought a new stake in shares of UnitedHealth Group during the 1st quarter valued at $14,343,000. Lee Johnson Capital Management LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $6,180,000. Kinsale Capital Group Inc. grew its position in shares of UnitedHealth Group by 13.4% in the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock worth $16,006,000 after buying an additional 4,557 shares during the period. Finally, Kelleher Financial Advisors increased its stake in shares of UnitedHealth Group by 135.9% in the 2nd quarter. Kelleher Financial Advisors now owns 5,495 shares of the healthcare conglomerate’s stock worth $2,284,000 after acquiring an additional 3,166 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about UnitedHealth Group

Here are a few of the latest headlines about UNH:

• Positive Sentiment: Recent commentary says analysts remain optimistic, and another article argues the shares may still be below fair value. It cites board changes and a sharper focus on medical-cost management and pricing as factors that could support earnings, though valuation depends on execution. Article: Do Wall Street Analysts Like UnitedHealth Group Stock? Article: UnitedHealth Group Stock Still Looks Below Fair Value After Board Appointment
• Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction
• Negative Sentiment: Optum Rx’s prescription volumes declined, highlighting ongoing membership-related pressure even as segment earnings improved. Whether efficiencies and biosimilar adoption can sustain profit growth will matter to investors. Article: Can UNH’s Optum Rx Sustain Profit Growth as Prescription Volumes Fall?

UnitedHealth Group Price Performance

UNH opened at $407.62 on Friday. The stock has a 50-day moving average price of $391.36 and a 200-day moving average price of $365.66. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The firm has a market cap of $365.23 billion, a PE ratio of 23.28, a P/E/G ratio of 1.47 and a beta of 0.51. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The company had revenue of $112.72 billion for the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. UnitedHealth Group’s revenue for the quarter was down .4% on a year-over-year basis. During the same period in the prior year, the firm posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be paid a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio is currently 53.00%.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.19% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms recently commented on UNH. Sanford C. Bernstein dropped their price objective on shares of UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 14th. Bank of America restated a “buy” rating and issued a $450.00 price objective on shares of UnitedHealth Group in a report on Monday, July 20th. Jefferies Financial Group raised their target price on shares of UnitedHealth Group from $401.00 to $490.00 and gave the company a “buy” rating in a research note on Friday, July 17th. Erste Group Bank lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, August 27th. Finally, Cantor Fitzgerald boosted their price target on UnitedHealth Group from $440.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.

About UnitedHealth Group

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.